Supplementary Table 1-3 from Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer
Chang Xu, Eduardo Méndez, Ryan Basom(Fred Hutch Cancer Center), Carlos L. Green, Adam A. Margolin(Broad Institute), Olga Nikolova(Oregon Health & Science University), Russell Moser(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Reid Shaw(Precision for Medicine (United States)), Hallie A. Swan(Precision for Medicine (United States)), Kay E. Gurley(Fred Hutch Cancer Center), Carla Grandori(Precision for Medicine (United States)), Vijayakrishna K. Gadi(Fred Hutch Cancer Center), Justin Guinney(Sage Bionetworks), Franz X. Schaub(Precision for Medicine (United States)), Ryan M. Mitchell(University of Washington), In S. Jang, Christopher J. Kemp(Fred Hutch Cancer Center), Heuijoon Park(Fred Hutch Cancer Center), Robert L. Diaz, Michael Kao(University of Washington Medical Center)
Cited by 0
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k